We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
-11.85%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$2.07B
AUM Growth
+$253M
Cap. Flow
+$528M
Cap. Flow %
25.51%
Top 10 Hldgs %
62.26%
Holding
297
New
23
Increased
108
Reduced
98
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 4.94%
2 Financials 1.93%
3 Communication Services 1.27%
4 Healthcare 1.04%
5 Consumer Staples 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGX icon
251
Invesco Preferred ETF
PGX
$3.81B
$223K 0.01%
17,991
GS icon
252
Goldman Sachs
GS
$309B
$218K 0.01%
737
-40
-5% -$12.5K
PEG icon
253
Public Service Enterprise Group
PEG
$39.5B
$217K 0.01%
3,434
-47
-1% -$3.19K
BOX icon
254
Box
BOX
$4.18B
$216K 0.01%
8,586
CI icon
255
Cigna
CI
$77B
$216K 0.01%
822
-43
-5% -$11.1K
SPLV icon
256
Invesco S&P 500 Low Volatility ETF
SPLV
$7.21B
$215K 0.01%
3,464
XLU icon
257
State Street Utilities Select Sector SPDR ETF
XLU
$23.5B
$214K 0.01%
6,114
-306
-5% -$11.1K
MET icon
258
MetLife
MET
$61.2B
$213K 0.01%
3,388
+42
+1% +$2.78K
NUSC icon
259
Nuveen ESG Small-Cap ETF
NUSC
$1.29B
$213K 0.01%
6,506
ILMN icon
260
Illumina
ILMN
$28.7B
$211K 0.01%
1,178
+24
+2% +$6.13K
TGT icon
261
Target
TGT
$63.7B
$211K 0.01%
1,492
-51
-3% -$9.78K
ACWX icon
262
iShares MSCI ACWI ex US ETF
ACWX
$11.4B
$210K 0.01%
4,671
-1,663
-26% -$80.5K
MS icon
263
Morgan Stanley
MS
$337B
$209K 0.01%
2,762
-99
-3% -$8.11K
IYE icon
264
iShares US Energy ETF
IYE
$1.71B
$204K 0.01%
5,356
IGR
265
CBRE Global Real Estate Income Fund
IGR
$712M
$115K 0.01%
15,775
HBI
266
DELISTED
Hanesbrands
HBI
$113K 0.01%
+11,000
New +$137K
NOK icon
267
Nokia
NOK
$51.8B
$110K 0.01%
23,830
MRCC
268
DELISTED
Monroe Capital Corp
MRCC
$90K ﹤0.01%
+10,000
New +$100K
SOFI icon
269
SoFi Technologies
SOFI
$21.7B
$82K ﹤0.01%
15,633
DNMR
270
DELISTED
Danimer Scientific, Inc.
DNMR
$54K ﹤0.01%
296
+46
+18% +$8.36K
PRVB
271
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$44K ﹤0.01%
+11,000
New +$52.1K
CANG
272
Cango Inc
CANG
$69.7M
$37K ﹤0.01%
1,650
SERA icon
273
Sera Prognostics
SERA
$80.3M
$28K ﹤0.01%
16,472
SLNO
274
DELISTED
Soleno Therapeutics
SLNO
$11K ﹤0.01%
3,820
+2,667
+231% +$7.38K
ADI icon
275
Analog Devices
ADI
$181B
-1,346
Closed -$221K

Similar funds

Aspiriant LLC's Q2 2022 Portfolio in Review

As of Q2 2022, Aspiriant LLC held 297 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Aspiriant LLC deployed $528M of net new capital in Q2 2022, opening 23 new positions and adding to 108 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.

By sector, the portfolio is most concentrated in Technology at 4.9% of assets, down from 9.5% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares Core Moderate Allocation ETF, an estimated $4.33M trimmed.

  • Aspiriant LLC's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 745,894 shares worth $23.6M.
  • Aspiriant LLC added most to Vanguard Tax-Exempt Bond Index Fund in Q2 2022, an estimated $267M increase.
  • Aspiriant LLC's biggest Q2 2022 reduction was iShares Core Moderate Allocation ETF, cutting an estimated $4.33M.
  • Aspiriant LLC fully exited Leidos in Q2 2022, selling an estimated $14.6M.
  • Aspiriant LLC's ten largest holdings make up 62% of its $2.07B portfolio in Q2 2022.
  • Aspiriant LLC opened 23 new positions and closed 23 in Q2 2022.
  • Aspiriant LLC's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.